Demand Media DMD 深 沪
已收盘 10-08 16:00:00 美东时间
6.35
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 6.35
- 总市值 0
- 52周最高 6.35
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 4.41
- 委 比 0.00%
- 总股本 --
- 历史最高 12.50
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.62
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多申万宏源：预计全球小核酸药物市场将加速增长 关注后续临床数据读出以及潜在海外授权
在技术持续进步、上市批准及临床验证不断增加的推动下，预计全球小核酸药物市场将加速增长，从2023年起以26.1%的复合年增长率在2033年达到467亿美元。 ...
09-26 10:19
Why Capricor Therapeutics Stock Is Surging Today
Shares of Capricor Therapeutics Inc. (NASDAQ: CAPR) are up Thursday after the company announced progress regarding one of its rare disease therapeutics.
09-25 23:16
Capricor Issues BLA Update For DMD Cell Therapy Deramiocel Following FDA Type A Meeting Post-CRL; HOPE-3 Pivotal Trial Topline Data Expected Mid-Q4 2025 To Support BLA Resubmission
FDA and Capricor aligned on endpoints for HOPE-3 pivotal trialHOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support BLA resubmissionCompany preparing to resubmit CRL response under the current BLAConference call and webcast scheduled for today at 8:30 a.m. ET
09-25 19:18
Solid Biosciences grants AAV-SLB101 license to Kinea Bio
Solid Biosciences (NASDAQ:SLDB) has entered into a collaboration with Kinea Bio, granting them a non-exclusive worldwide license to use Solid’s AAV-SLB101 capsid. This partnership focuses on the devel...
09-23 21:41
影院级视听体验，海信激光电视探索X1 Ultra亮相青博会
9月19日至21日，以“智联万物 AI赋未来”为主题的2025年中国国际消费电子博览会（青博会）在青岛开幕。在智能化与个性化消费并重的时代，家庭影院产品的用户需...
09-22 19:43
募资5亿美元加码核心管线！Avidity(RNA.US)获美银唱好 目标价看高至65美元
美国银行发表研报，予以Avidity Biosciences Inc. “买入”评级，并将目标价从56美元上调至65美元。
09-15 11:59
Avidity Biosciences prices $600M stock offering
Avidity Biosciences (NASDAQ:RNA) has priced an upsized offering of 15M shares at $40 each to raise gross proceeds of $600M. In addition, the biopharmaceutical company has granted the underwriters a 30...
09-12 12:43
Farmmi files to sell 12.5M ordinary shares for holders
Farmmi (NASDAQ:FAMI) filed to sell 12.5M ordinary shares for holders. This preliminary prospectus is not an offer to sell. Filing More on NCino, Inc. (NCNO) Presents At Piper Sandler Growth Frontiers ...
09-12 04:48
Avidity Biosciences reports data from DMD treatment trials
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy. After one year of continuous treatment,...
09-12 04:43
Avidity Biosciences launches $500M proposed public offering
Avidity Biosciences (NASDAQ:RNA) intends to offer and sell $500.0 million of shares of its common stock in an underwritten public offering. Avidity intends to use the net proceeds from this offering, ...
09-11 04:06
